{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:23Z","timestamp":1791910343350,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118292","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:14:48Z","timestamp":1785194088000},"page":"118292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Targeting chitinase-3-like protein-1 in pancolitis by a drug-repurposing approach"],"prefix":"10.1016","volume":"253","author":[{"given":"Faranak","family":"Bahramimehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Guthart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Fromm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Tarasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanping","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Shahhamzehei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcmeysa","family":"Y\u00fccer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Dieter","family":"Schulzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bringmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-1681","authenticated-orcid":false,"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2026.118292_b0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative Colitis in adults: a Review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.bcp.2026.118292_b0010","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i19.106406","article-title":"Comparative study on the pathogenesis of Crohn's disease and ulcerative colitis","volume":"31","author":"Yang","year":"2025","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118292_b0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","article-title":"Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes","volume":"26","author":"Yu","year":"2017","journal-title":"Semin. Pediatr. Surg."},{"issue":"8","key":"10.1016\/j.bcp.2026.118292_b0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/07853890.2016.1195011","article-title":"Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases","volume":"48","author":"Col\u00eca","year":"2016","journal-title":"Ann. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118292_b0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.mib.0000179469.86500.ac","article-title":"Optimizing therapy in patients with pancolitis","volume":"11","author":"Cuffari","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2026.118292_b0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2011.00098","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118292_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2013.07.032","article-title":"Chronic ulcerative colitis and colorectal cancer","volume":"345","author":"Rogler","year":"2014","journal-title":"Cancer Lett."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2026.118292_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.18.s2.2.x","article-title":"Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease","volume":"18","author":"Munkholm","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.118292_b0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-022-00931-1","article-title":"Natural compounds as safe therapeutic options for ulcerative colitis","volume":"30","author":"Gupta","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"10401","key":"10.1016\/j.bcp.2026.118292_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bcp.2026.118292_b0055","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2174\/138945011796818126","article-title":"Is 5-ASA still the treatment of choice for ulcerative colitis?","volume":"12","author":"Cottone","year":"2011","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0060","first-page":"233","article-title":"Systems biology in inflammatory bowel diseases: on the way to precision medicine","volume":"32","author":"Dovrolis","year":"2019","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.118292_b0065","doi-asserted-by":"crossref","unstructured":"J.E. Yu JE, I.J. Yeo, S.B. Han, J. Yun, B. Kim, Y.J. Yong, Y.S. Lim, T.H. Kim, D.J. Son, J.T. Hong,. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer, Exp. Mol. Med. 56(1) (2024) 1-18. doi: 10.1038\/s12276-023-01131-9.","DOI":"10.1038\/s12276-023-01131-9"},{"key":"10.1016\/j.bcp.2026.118292_b0070","doi-asserted-by":"crossref","unstructured":"\u00d6. Kur\u00e7, N. R\u00e4hse, H. Gohlke, J. Cramer J. Human chitinases and chitinase-like proteins as emerging drug targets - a medicinal chemistry perspective, RSC Med. Chem. 16(6) (2025) 2388-2402. doi: 10.1039\/d4md01050g.","DOI":"10.1039\/D4MD01050G"},{"issue":"5","key":"10.1016\/j.bcp.2026.118292_b0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4062\/biomolther.2025.050","article-title":"Chitinase-3-like Protein 1 as a Therapeutic Target for Inflammatory Diseases","volume":"33","author":"Gu","year":"2025","journal-title":"Biomol. Ther. (seoul)"},{"key":"10.1016\/j.bcp.2026.118292_b0080","doi-asserted-by":"crossref","unstructured":"S. Pushpakom, F. Iorio, P.A. Eyers, K.J., S. Hopper, A. Wells, A. Doig, T. Guilliams, J. Latimer, C. McNamee, A. Norris, P. Sanseau, D. Cavalla, M. Pirmohamed, Drug repurposing: progress, challenges and recommendations, Nat. Rev. Drug Discov. 18(1) (2019) 41-58. doi: 10.1038\/nrd.2018.168.","DOI":"10.1038\/nrd.2018.168"},{"key":"10.1016\/j.bcp.2026.118292_b0085","doi-asserted-by":"crossref","unstructured":"S.S. Sadeghi, M.R. Keyvanpour, An Analytical Review of Computational Drug Repurposing. IEEE\/ACM Trans Comput, Biol. Bioinform. 18(2) (2021) 472-488. doi: 10.1109\/TCBB.2019.2933825.","DOI":"10.1109\/TCBB.2019.2933825"},{"issue":"10","key":"10.1016\/j.bcp.2026.118292_b0090","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/ecco-jcc\/jjx075","article-title":"Genetic Mouse Models with Intestinal-specific Tight Junction Deletion Resemble an Ulcerative Colitis Phenotype","volume":"11","author":"Stremmel","year":"2017","journal-title":"J. Crohns Colitis"},{"issue":"9","key":"10.1016\/j.bcp.2026.118292_b0095","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/molecules30091897","article-title":"Drug Repurposing to Inhibit Oncostatin M in Crohn's Disease","volume":"30","author":"Bahramimehr","year":"2025","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bcp.2026.118292_b0100","first-page":"1547","article-title":"Single-blind","volume":"32","author":"Hai","year":"2022","journal-title":"Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease, Thyroid"},{"issue":"39","key":"10.1016\/j.bcp.2026.118292_b0105","doi-asserted-by":"crossref","first-page":"37753","DOI":"10.1074\/jbc.M303137200","article-title":"Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39","volume":"278","author":"Fusetti","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2026.118292_b0110","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s00535-017-1309-2","article-title":"Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8","volume":"52","author":"Barmeyer","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118292_b0115","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1189\/jlb.0408231","article-title":"The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice","volume":"84","author":"Bento","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118292_b0120","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2174\/156802610791561246","article-title":"Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disorders","volume":"10","author":"Dwyer","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118292_b0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1535370213520110","article-title":"Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases","volume":"239","author":"Boppana","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bcp.2026.118292_b0130","doi-asserted-by":"crossref","unstructured":"S.I. Rennard, D.C. Dale, J.F. Donohue, F. Kanniess, H. Magnussen, E.R. Sutherland, H. Watz, S. Lu, P. Stryszak, E. Rosenberg, H. Staudinger, CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease, Am. J. Respir. Crit. Care Med. 191(9) (2015) 1001-1011. doi: 10.1164\/rccm.201405-0992OC.","DOI":"10.1164\/rccm.201405-0992OC"},{"issue":"9","key":"10.1016\/j.bcp.2026.118292_b0135","first-page":"5237","article-title":"Blockade of CXCR2 suppresses proinflammatory activities of neutrophils in ulcerative colitis","volume":"12","author":"Zhu","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bcp.2026.118292_b0140","doi-asserted-by":"crossref","unstructured":"P. Jia, C.F. Kao, P.H. Kuo, Z. Zhao, A comprehensive network and pathway analysis of candidate genes in major depressive disorder, BMC Syst. Biol. 5 Suppl 3(Suppl 3) (2011) S12. doi: 10.1186\/1752-0509-5-S3-S12.","DOI":"10.1186\/1752-0509-5-S3-S12"},{"key":"10.1016\/j.bcp.2026.118292_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767456","article-title":"IL-1\u03b2 and the Intestinal Epithelial Tight Junction Barrier","volume":"12","author":"Kaminsky","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118292_b0150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/path.2253","article-title":"Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoforms","volume":"213","author":"Kern","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2026.118292_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117924","article-title":"Lead optimization of a CHI3L1 inhibitor for Glioblastoma: Enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid models","volume":"297","author":"Kaur","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2026.118292_b0160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00280-024-04712-1","article-title":"Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma","volume":"94","author":"Sousa","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118292_b0165","article-title":"Heparin-binding of the human chitinase-like protein YKL-40 is allosterically modified by chitin oligosaccharides","volume":"41","author":"Magnusdottir","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"20","key":"10.1016\/j.bcp.2026.118292_b0170","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2174\/1568026618666181025112344","article-title":"Recent advances in the System Biology-based Target Identification and Drug Discovery","volume":"18","author":"Yadav","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2018.01.018","article-title":"A bibliometric review of drug repurposing","volume":"23","author":"Baker","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2026.118292_b0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","article-title":"Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer","volume":"56","author":"Yu","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0195","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ajpath.2011.05.038","article-title":"Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia","volume":"179","author":"Chen","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118292_b0200","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2174\/1566524011313070006","article-title":"Potential association between TLR4 and chitinase 3-like 1 (CHI3L1\/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer","volume":"13","author":"Kamba","year":"2013","journal-title":"Curr. Mol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118292_b0205","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/acsmedchemlett.5c00550","article-title":"Virtual Screening-Guided Discovery of Small-Molecule CHI3L1 Inhibitors with Functional activity in Glioblastoma Spheroids","volume":"16","author":"Kaur","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2026.118292_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130460","article-title":"Discovery of small molecule CHI3L1 inhibitors by SPR-based high-throughput screening","volume":"131","author":"Zhang","year":"2026","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118292_b0220","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2018.01.023","article-title":"CCL18 - beyond chemotaxis","volume":"109","author":"Chenivesse","year":"2018","journal-title":"Cytokine"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2026.118292_b0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cytogfr.2011.09.002","article-title":"The expression and role of CXC chemokines in colorectal cancer","volume":"22","author":"Verbeke","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.bcp.2026.118292_b0230","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141676","article-title":"DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk","volume":"131","author":"Grasberger","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0235","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01.MIB.0000442012.45038.0e","article-title":"DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid","volume":"20","author":"MacFie","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2026.118292_b0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2022.09.004","article-title":"Role of gremlin-1 in the pathophysiology of the adipose tissues","volume":"69","author":"Grillo","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"24","key":"10.1016\/j.bcp.2026.118292_b0245","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1111\/febs.15701","article-title":"Multifunctional intracellular matrix metalloproteinases: implications in disease","volume":"288","author":"Bassiouni","year":"2021","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.bcp.2026.118292_b0250","first-page":"1317","article-title":"Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD)","volume":"55","author":"Silo\u015fi","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0255","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41418-021-00880-2","article-title":"Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-\u03b2-catenin-STAT3 signaling","volume":"29","author":"Hu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118292_b0260","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in Inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118292_b0265","first-page":"e416","article-title":"Immune Mediator Pharmacogenomics: TCL1A SNPs and Estrogen-Dependent Regulation of Inflammation","volume":"3","author":"Ho","year":"2017","journal-title":"J. Nat. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00384-002-0446-z","article-title":"Increased serum levels of YKL-40 in patients with inflammatory bowel disease","volume":"18","author":"Koutroubakis","year":"2003","journal-title":"Int. J. Colorectal Dis."},{"issue":"24","key":"10.1016\/j.bcp.2026.118292_b0275","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.3390\/ijms252413437","article-title":"Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: a Comprehensive Review","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"34","key":"10.1016\/j.bcp.2026.118292_b0280","doi-asserted-by":"crossref","first-page":"36535","DOI":"10.18632\/oncotarget.5440","article-title":"Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9","volume":"6","author":"Low","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118292_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107394","article-title":"Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases","volume":"203","author":"Yeo","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.bcp.2026.118292_b0290","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/cells14130982","article-title":"Future Perspectives and Conclusions from Animal Models of CHI3L1-Related Inflammation-Associated Cancer","volume":"14","author":"Mizoguchi","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118292_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104359","article-title":"Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning","volume":"133","author":"Kadioglu","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118292_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106781","article-title":"A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening","volume":"157","author":"Kadioglu","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-017-0128-7","article-title":"Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects","volume":"18","author":"Chartier","year":"2017","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118292_b0310","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.drudis.2021.02.003","article-title":"Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts","volume":"26","author":"Yang","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2026.118292_b0315","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acs.jctc.5b00834","article-title":"Vina-Carb: improving Glycosidic Angles during Carbohydrate Docking","volume":"9;12(2)","author":"Nivedha","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.bcp.2026.118292_b0320","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s11255-023-03804-w","article-title":"Repurposing fexofenadine as a promising candidate for diabetic kidney disease: randomized clinical trial","volume":"56","author":"El-Fatatry","year":"2024","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-024-03041-7","article-title":"Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's disease","volume":"21","author":"Kim","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bcp.2026.118292_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70034","article-title":"Lifitegrast, a Lymphocyte Function-Associated Antigen-1 Antagonist Demonstrates Beneficial effect in Psoriasis","volume":"85","author":"Gawande","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118292_b0335","article-title":"Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci. (weinh.)"},{"key":"10.1016\/j.bcp.2026.118292_b0340","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/1389450119666171227224655","article-title":"Fenofibrate and Telmisartanin the Management of Abdominal aortic Aneurysm","volume":"19","author":"Rowbotham","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"11","key":"10.1016\/j.bcp.2026.118292_b0345","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.injury.2022.08.046","article-title":"Effect of angiotensin II pathway inhibitors on post-surgical adhesion band formation: a potential repurposing of old drugs","volume":"53","author":"Nazari","year":"2022","journal-title":"Injury"},{"key":"10.1016\/j.bcp.2026.118292_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107860","article-title":"Telmisartan reverses hepatic steatosis via PCK1 upregulation: a novel PPAR-independent mechanism in experimental models of MASLD","volume":"218","author":"Bentanachs","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118292_b0355","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40265-018-0895-5","article-title":"Sofosbuvir\/Velpatasvir\/Voxilaprevir: a Review in Chronic Hepatitis C","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2026.118292_b0360","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2147\/IDR.S171338","article-title":"Profile of sofosbuvir\/velpatasvir\/voxilaprevir in the treatment of hepatitis C","volume":"12","author":"Childs-Kean","year":"2019","journal-title":"Infect. Drug Resist."},{"issue":"8","key":"10.1016\/j.bcp.2026.118292_b0365","article-title":"Sofosbuvir\/Velpatasvir - a Promising Treatment for Chronic Hepatitis C Virus Infection","volume":"13","author":"Ahmed","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.bcp.2026.118292_b0370","doi-asserted-by":"crossref","unstructured":"M.P. Curry, J.G. O'Leary, N. Bzowej, A.J. Muir, K.M. Korenblat, J.M. Fenkel, K.R. Reddy, E. Lawitz, S.L. Flamm, T. Schiano, L. Teperman, R. Fontana, E. Schiff, M. Fried, B. Doehle, D. An, J. McNally, A. Osinusi, D.M. Brainard, J.G. McHutchison, R.S. Brown Jr, M. Charlton, ASTRAL-4 Investigators, Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis, N. Engl. J. Med. 373 (27), 2618-2628. https:\/\/doi.org\/10.1056\/NEJMoa1512614.","DOI":"10.1056\/NEJMoa1512614"},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0375","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/liv.13534","article-title":"Sofosbuvir\/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.bcp.2026.118292_b0380","first-page":"187","article-title":"Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis","volume":"90","author":"Pisaturo","year":"2019","journal-title":"Acta Biomed"},{"key":"10.1016\/j.bcp.2026.118292_b0385","article-title":"Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C","volume":"11","author":"Ma","year":"2024","journal-title":"Front. Med. (lausanne)."},{"issue":"42","key":"10.1016\/j.bcp.2026.118292_b0390","doi-asserted-by":"crossref","first-page":"95660","DOI":"10.1007\/s11356-023-29134-z","article-title":"An insight into the hepatoprotective role of Velpatasvir and Sofosbuvir per se and in combination against carbon tetrachloride-induced hepatic fibrosis in rats","volume":"30","author":"Yasmeen","year":"2023","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.bcp.2026.118292_b0395","doi-asserted-by":"crossref","unstructured":"B. Sayad, R. Khodarahmi, F. Najafi, R. Miladi, Z. Mohseni Afshar, F. Mansouri, Z. Rahimi, M. Shirvani, M. Salimi, S. Vaziri, A. Janbakhsh, F. Khosravi Shadmani, A. Bozorgomid, M.H. Zamanian, M. Afsharian, Efficacy and safety of sofosbuvir\/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial, J. Antimicrob. Chemother. 76(8) (2021) 2158-2167. doi: 10.1093\/jac\/dkab152.","DOI":"10.1093\/jac\/dkab152"},{"issue":"12","key":"10.1016\/j.bcp.2026.118292_b0405","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/ph18121857","article-title":"Repurposing of FDA-Approved Antiviral Drugs against Monkeypox Virus: Comparative In Vitro Screening and Structure based In Silico Studies","volume":"18","author":"Moatasim","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118292_b0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14744\/nci.2026.85353","article-title":"Repurposing antiviral drugs targeting RNA viruses: a focus on the fusion protein of human metapneumovirus","volume":"13","author":"Aras","year":"2026","journal-title":"North Clin. Istanb."},{"issue":"2","key":"10.1016\/j.bcp.2026.118292_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0342559","article-title":"Repurposing antiviral agents against mucormycosis","volume":"21","author":"Khan","year":"2026","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bcp.2026.118292_b0420","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14728222.2018.1515917","article-title":"Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies","volume":"22","author":"Gupta","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0425","doi-asserted-by":"crossref","DOI":"10.1177\/00368504251413427","article-title":"Integrative multiomics dissection of LSM7 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma","volume":"109","author":"Fan","year":"2026","journal-title":"Sci. Prog."},{"issue":"3","key":"10.1016\/j.bcp.2026.118292_b0430","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s40203-025-00495-2","article-title":"In silico screening of potential FGF2 inhibitors for cancer therapy","volume":"13","author":"Senrung","year":"2025","journal-title":"In Silico Pharmacol."},{"key":"10.1016\/j.bcp.2026.118292_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108235","article-title":"Drug repositioning identifies potential autophagy inhibitors for the LIR motif p62\/SQSTM1 protein","volume":"113","author":"Asghari","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118292_b0440","doi-asserted-by":"crossref","first-page":"540","DOI":"10.21873\/cgp.20339","article-title":"Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells","volume":"19","author":"Saeed","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"12","key":"10.1016\/j.bcp.2026.118292_b0445","article-title":"Lomitapide repurposing for treatment of malignancies: a promising direction","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon 13"},{"issue":"6","key":"10.1016\/j.bcp.2026.118292_b0450","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00894-020-04406-4","article-title":"In silico identification of new inhibitors for \u03b2eta-2-glycoprotein I as a major antigen in antiphospholipid antibody syndrome","volume":"26","author":"Mahdian","year":"2020","journal-title":"J. Mol. Model."},{"issue":"12","key":"10.1016\/j.bcp.2026.118292_b0455","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/MIB.0000000000001262","article-title":"Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit","volume":"23","author":"Hyams","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"42","key":"10.1016\/j.bcp.2026.118292_b0460","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.3748\/wjg.v20.i42.15736","article-title":"Increased expression and possible role of chitinase 3-like-1 in a colitis-associated carcinoma model","volume":"20","author":"Ma","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118292_b0465","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijo.2021.5293","article-title":"Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer","volume":"60","author":"Watanabe","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"26","key":"10.1016\/j.bcp.2026.118292_b0470","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/onc.2011.498","article-title":"Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer","volume":"31","author":"Kawada","year":"2012","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bcp.2026.118292_b0480","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12032-014-0085-6","article-title":"Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer","volume":"31","author":"Liu","year":"2014","journal-title":"Med. Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:23:47Z","timestamp":1791908627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":94,"alternative-id":["S0006295226006313"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118292","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting chitinase-3-like protein-1 in pancolitis by a drug-repurposing approach","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118292"}}